catechin has been researched along with Cancer of Head in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, L; Li, X; Mei, H; Meng, X; Xing, L; Yu, J; Zhao, H; Zhao, X; Zhu, W | 1 |
| Beitler, JJ; Chen, AY; Chen, Z; Chen, ZG; El-Deiry, MW; Khuri, FR; Klein, AM; Liu, Y; Nannapaneni, S; Owonikoko, TK; Patel, MR; Ramalingam, SS; Roser, SM; Saba, NF; Shi, Q; Shin, DM; Steuer, CE | 1 |
| Amin, ARMR; Chen, ZG; Lamichhane, R; Nannapaneni, S; Shin, DM; Wang, D | 1 |
| Atwi, D; Banerjee, P; Fried, A; Hussaini, R; Mukherjee, S; Pan, Q; Piao, L; Sampat, S; White, R | 1 |
| Kang, SU; Kim, CH; Kim, JH; Oh, YT; Park, KH; Shin, HA; Shin, YS | 1 |
| Kang, HJ; Kwon, HW; Lee, SH; Lim, YC; Nam, HJ | 1 |
| Chen, WT; Chen, YJ; Chung, LC; Feng, TH; Juang, HH; Lee, JC | 1 |
| Chen, ZG; Haque, A; Khuri, FR; Rahman, MA; Ruhul Amin, AR; Saba, NF; Shin, DM | 1 |
| Baek, SJ; Kang, SU; Kim, CH; Kim, YE; Kim, YS; Lee, SH; Park, JK; Shin, YS | 1 |
| Katiyar, SK | 1 |
| Chen, Z'; Khuri, FR; Lee, JE; Shin, DM; Shin, HJ; Tighiouart, M; Yang, CS; Zhang, H; Zhang, X | 1 |
| Amin, AR; Chen, ZG; Khuri, FR; Shin, DM | 1 |
| Amin, AR; Kim, JW; Shin, DM | 1 |
| Amin, AR; Brandes, JC; Chen, ZG; Khuri, FR; Peng, S; Shin, DM; Shin, HJ; Tighiouart, M; Wang, D; Zhang, H | 1 |
| Amin, AR; Rahman, MA; Shin, DM | 1 |
| Chen, SC; Funayama, S; Ho, CT; Hou, SC; Kao, MC; Lin, HY; Way, TD; Yu, CC | 1 |
| Baumeister, P; Harréus, U; Reiter, M | 1 |
| Baek, SJ; Kang, SU; Kim, CH; Lee, BS; Lee, SH; Shin, YS | 1 |
| Cai, GM; Hunag, DH; Liu, Y; Pi, LM; Qiu, YZ; Tian, YQ; Yu, CY; Zhang, X | 1 |
| Lim, JT; Masuda, M; Suzui, M; Weinstein, IB | 1 |
| Baek, SJ; Choi, EC; Lee, SH; Lim, YC; Song, MH; Yamaguchi, K; Yoon, JH | 1 |
3 review(s) available for catechin and Cancer of Head
| Article | Year |
|---|---|
Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Evaluation, Preclinical; Head and Neck Neoplasms; Humans; Lignans; Magnolia; Polyphenols; Proanthocyanidins; Squamous Cell Carcinoma of Head and Neck; Tea; Vitis | 2016 |
Chemoprevention of head and neck cancer with green tea polyphenols.
Topics: Animals; Carcinoma, Squamous Cell; Catechin; Chemoprevention; Flavonoids; Head and Neck Neoplasms; Humans; Models, Biological; Phenols; Plant Extracts; Polyphenols; Tea | 2010 |
Chemopreventive potential of natural compounds in head and neck cancer.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Catechin; Curcumin; Cyclooxygenase 2 Inhibitors; ErbB Receptors; Head and Neck Neoplasms; Humans; NF-kappa B; Resveratrol; Stilbenes; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2010 |
3 trial(s) available for catechin and Cancer of Head
| Article | Year |
|---|---|
Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial.
Topics: Adult; Aged; Catechin; Chemoradiotherapy; Head and Neck Neoplasms; Humans; Maximum Tolerated Dose; Middle Aged; Mouth Mucosa; Mouthwashes; Mucositis; Prospective Studies; Radiation Injuries; Young Adult | 2020 |
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catechin; Erlotinib Hydrochloride; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Middle Aged; Precancerous Conditions; Progression-Free Survival; Protein Kinase Inhibitors; Tea | 2020 |
Green tea and leukoplakia. The Indian-US Head and Neck Cancer Cooperative Group.
Topics: Adult; Aged; Antineoplastic Agents; Catechin; Chemoprevention; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; India; Leukoplakia, Oral; Male; Middle Aged; Patient Compliance; Risk Factors; Tea | 1997 |
16 other study(ies) available for catechin and Cancer of Head
| Article | Year |
|---|---|
Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Carcinogenesis; Catechin; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Head and Neck Neoplasms; Humans; Mice; Resveratrol; Signal Transduction; Tea; Xenograft Model Antitumor Assays | 2021 |
TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Catechin; Curcumin; Female; Head and Neck Neoplasms; Humans; Killer Cells, Natural; Lung Neoplasms; Macrophages; Mice; Mice, Inbred C57BL; Mice, Nude; Papillomaviridae; Papillomavirus Infections; Resveratrol; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Effect of epicatechin against radiation-induced oral mucositis: in vitro and in vivo study.
Topics: Analysis of Variance; Animals; Apoptosis; Blotting, Western; Catechin; Female; Fluorescein-5-isothiocyanate; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Keratinocytes; Membrane Potential, Mitochondrial; Microscopy, Fluorescence; Propidium; Radiotherapy; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Stomatitis | 2013 |
Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Multidrug Resistance-Associated Protein 2; Neoplastic Stem Cells; Receptors, Notch; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Transfection; Xenograft Model Antitumor Assays | 2013 |
Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.
Topics: Animals; Carcinoma, Squamous Cell; Catechin; Cell Growth Processes; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; G1 Phase Cell Cycle Checkpoints; Gene Knockdown Techniques; Head and Neck Neoplasms; Humans; Immediate-Early Proteins; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Squamous Cell Carcinoma of Head and Neck; Tumor Suppressor Proteins; Up-Regulation; Xenograft Model Antitumor Assays | 2015 |
Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2.
Topics: Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Catechin; Cell Line, Tumor; Cycloheximide; Drug Synergism; Erlotinib Hydrochloride; Extracellular Signal-Regulated MAP Kinases; Head and Neck Neoplasms; Humans; Membrane Proteins; Phosphorylation; Protein Biosynthesis; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; RNA Interference | 2015 |
Anti-cancer effect of (-)-epigallocatechin-3-gallate (EGCG) in head and neck cancer through repression of transactivation and enhanced degradation of β-catenin.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Catechin; Cell Line, Tumor; Cell Proliferation; Female; Gene Knockdown Techniques; Genes, p53; Head and Neck Neoplasms; Humans; Male; Mice; Mice, Inbred C3H; Middle Aged; Neoplasm Transplantation; Signal Transduction; Transcriptional Activation; Ubiquitin-Specific Proteases | 2016 |
Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Disease Progression; Drug Synergism; Enzyme Inhibitors; ErbB Receptors; Erlotinib Hydrochloride; Flow Cytometry; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Nude; Protein-Tyrosine Kinases; Quinazolines; Transplantation, Heterologous | 2008 |
Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Catechin; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; NF-kappa B; Protein Kinase Inhibitors; Quinazolines; RNA, Small Interfering; Transcription Factor RelA; Tumor Suppressor Protein p53 | 2009 |
Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Caspase 3; Catechin; Cell Cycle Proteins; Cell Line, Tumor; DNA Damage; DNA-Binding Proteins; Drug Synergism; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Luteolin; Mice; Mice, Nude; Mitochondria; Neoplasm Transplantation; Phosphorylation; Protein Serine-Threonine Kinases; Protein Stability; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2010 |
(-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells.
Topics: Apoptosis; Carcinoma, Squamous Cell; Catechin; Down-Regulation; Fas Ligand Protein; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Interleukin-6; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor | 2012 |
Curcumin and other polyphenolic compounds in head and neck cancer chemoprevention.
Topics: Antimutagenic Agents; Catechin; Cell Survival; Cells, Cultured; Curcumin; DNA Damage; Head and Neck Neoplasms; Humans; Nicotiana; Polyphenols | 2012 |
Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression.
Topics: Anticarcinogenic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Growth Differentiation Factor 15; Head and Neck Neoplasms; Heterografts; Humans; RNA, Small Interfering; Squamous Cell Carcinoma of Head and Neck; Tumor Suppressor Protein p53 | 2013 |
[EGCG regulates TGF-β1-induced epithelial mesenchymal transition in squamous cell carcinoma of head and neck].
Topics: Antigens, CD; Cadherins; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Head and Neck Neoplasms; Humans; Signal Transduction; Smad7 Protein; Squamous Cell Carcinoma of Head and Neck; Transforming Growth Factor beta1; Vimentin | 2012 |
Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Breast Neoplasms; Carcinoma; Catechin; Cell Division; Cell Line, Tumor; Cyclin D1; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Genes, Reporter; Head and Neck Neoplasms; Humans; Immunoblotting; Luciferases; Paclitaxel; Phosphorylation; Prognosis; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Receptor, ErbB-2; Signal Transduction; Time Factors | 2003 |
Growth inhibition and apoptosis by (-)-epicatechin gallate are mediated by cyclin D1 suppression in head and neck squamous carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cyclin D1; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Flavonoids; Flow Cytometry; Growth Differentiation Factor 15; Growth Inhibitors; Head and Neck Neoplasms; Humans; Neoplasm Proteins; Phenols; Polyphenols | 2006 |